Validation Data Gallery
|Positive WB detected in||human placenta tissue, human brain tissue, HUVEC cells|
|Positive IP detected in||human placenta tissue|
|Positive IHC detected in||human spleen tissue|
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
|Positive IF detected in||MCF-7 cells|
|Western Blot (WB)||WB : 1:500-1:2000|
|Immunoprecipitation (IP)||IP : 0.5-4.0 ug for IP and 1:500-1:1000 for WB|
|Immunohistochemistry (IHC)||IHC : 1:50-1:500|
|Immunofluorescence (IF)||IF : 1:10-1:100|
|Sample-dependent, check data in validation data gallery|
15303-1-AP targets GBP1 in WB, RIP, IP, IHC, IF, ELISA applications and shows reactivity with human samples.
|Cited Reactivity||human, mouse|
|Host / Isotype||Rabbit / IgG|
|Immunogen||GBP1 fusion protein Ag7562|
|Full Name||GTP binding protein 1|
|Calculated molecular weight||68 kDa|
|Observed molecular weight||67 kDa|
|GenBank accession number||BC002666|
|Gene ID (NCBI)||2633|
|Purification Method||Antigen affinity purification|
|Storage Buffer||PBS with 0.02% sodium azide and 50% glycerol pH 7.3.|
|Storage Conditions||Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.|
Guanylate binding protein 1 (GBP1) belongs to the dynamin superfamily of large GTPases. The expression of GBP1 is induced by IFN and GBP1 is characterized by its ability to specifically bind guanine nucleotides such as GMP, GDP, and GTP and its ability to hydrolyze GTP to GDP and GMP.
What is the molecular weight of GBP1?
The molecular weight of GBP1 is 68kDa.
What is the cellular localization of GBP1?
GBP1 is predominantly cytosolic, but under certain conditions is farnesylated and associated with intracellular membranes such as the Golgi (PMID: 15937107).
What is the role of GBP1 in immunity?
GBP1 is induced in response to type I and type II IFN and as such plays a role in protective immunity against a spectrum of intracellular pathogens ranging from viruses to bacteria to protozoa, such as negative-strand RNA Rhabdovirus, vesicular stomatitis virus and the positive-strand RNA Picornovirus, encephalomyocarditis virus in cultured cells, the inhibition of Chlamydia trachomatis, Toxoplasma gondii, and Salmonella enterica (PMID: 21142871). These anti-pathogenic functions involve the recruitment to vacuolar compartments for the destruction of the pathogen, the assembly of innate immune complexes such as the inflammasome, or the initiation of autophagy.
What is the role of GBP-1 in colorectal carcinoma?
In colorectal carcinoma (CRC), the presence of tumor-infiltrating T helper type 1 (Th1) cells participates in anti-tumoral responses and an improved clinical outcome (PMID: 17008531, 20927778). IFN promote the Th1 immune response, as well as GBP-1 expression. In CRC, GBP-1 expression acts as a tumor suppressor, where inhibition of tumor growth by GBP-1 is the result of its strong antiangiogenic activity as well as its direct anti-tumorigenic effect on tumor cells and is correlated with a better outcome (PMID: 23042300).
|Product Specific Protocols|
|WB protocol for GBP1 antibody 15303-1-AP||Download protocol|
|IHC protocol for GBP1 antibody 15303-1-AP||Download protocol|
|IF protocol for GBP1 antibody 15303-1-AP||Download protocol|
|IP protocol for GBP1 antibody 15303-1-AP||Download protocol|
|Click here to view our Standard Protocols|
Guanylate-binding proteins convert cytosolic bacteria into caspase-4 signaling platforms.
Nat Cell Biol
LIMIT is an immunogenic lncRNA in cancer immunity and immunotherapy.
Cell Host Microbe
GBPs Inhibit Motility of Shigella flexneri but Are Targeted for Degradation by the Bacterial Ubiquitin Ligase IpaH9.8.
Mechanistic insight into bacterial entrapment by septin cage reconstitution.
Aging (Albany NY)
Immune profiling reveals prognostic genes in high-grade serous ovarian cancer.